T1International is a non-profit organization led by people with and impacted by diabetes, advocating for global healthcare equity and access to insulin and diabetes supplies for all, regardless of background or location.
2019
84-2544817
$341.2 thousand
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
T1International urges WHO to reject funding from pharmaceutical companies to protect patient advocacy.
Highlighting the ongoing insulin crisis and the need for immediate action.
Celebrating global advocacy efforts and community engagement for diabetes access.
Lowered Insulin Prices
Successfully pressured major insulin manufacturers to announce price reductions for insulin.
Fight for Five Campaign
Advocated for insulin and glucose testing supplies to cost no more than 5% of a person's income.
Essential Medicines List Inclusion
Ensured that Long-Acting Insulin Analogues were added to the WHO Essential Medicines List.
Overall Score
53
36
/100
Program Expense Ratio
59.47%
4
/20
Program Revenue Growth
-81.82%
2
/20
Leverage Ratio
0.01593
20
/20
Working Capital Ratio
0.7314
8
/20
Fundraising Efficiency
0
2
/20
Fiscal Year:2023
Source:Source: Self-reported by organization
Category | Amount | Percentage |
---|---|---|
Contributions, Gifts, and Grants | 362.6K | 96.96% |
Program Services | 10K | 2.67% |
Investment Income | 0 | 0.00% |
Sales of Non-Inventory Assets | 0 | 0.00% |
Other Notable Sources | 0 | 0.00% |
Total Revenue | 374K | 100.00% |
Health Associations
Health Research InstitutionHealth Associations
Health Research InstitutionHealth Associations
Health Research InstitutionHealth Associations
Health Research InstitutionHealth Associations
Health Research Institution